A psychiatrist who worked with the group that discovered ketamine’s antidepressant effects traces the path to the randomized trial he’s now leading to compare ketamine with electronconvulsive therapy.
Our new trial is pairing short-term ketamine therapy with the CAMS methodology over the long term in an attempt to reduce suicidality in adolescents and young adults.
The newly approved intranasal ketamine derivative helps fill clear gaps in short-term therapy, says one expert, but questions remain around its long-term effects and affordability.
Ketamine has emerged as an alternative to electroconvulsive therapy for treatment-resistant depression, but no study has compared the two. A major research project led by Cleveland Clinic is changing that.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Rett syndrome is a rare but debilitating genetic neurodevelopmental with no cure. Cleveland Clinic and Case Western Reserve University researchers are exploring ketamine as a possible treatment.